Akouos is a series b startup based in United States. 1 investor tracked. Status: acquired.
akouos is a company founded in 2015 headquartered in the United States. akouos has been acquired. Brouky records 4 investors associated with the company.
Akouos is a precision genetic medicine company focused on developing gene therapies to restore, improve, and preserve high-acuity physiologic hearing for people worldwide who live with disabling hearing loss.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.